Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 2 Peripheral Nervous System Diseases 2 Neurofibromatosis 1 2 Lung Neoplasms 2 Liver Neoplasms 2 Weight Loss 1 Tongue Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Renal Artery Obstruction 1 Radiation-Induced Mucositis 1 Pulmonary Embolism 1 Primary Graft Dysfunction 1 Ototoxicity 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Myofibroma 1 Muscular Atrophy 1 Mucositis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Failure, Acute 1 Liver Failure 1 Liver Diseases 1 Insulin Resistance 1 Inflammation 1

Interventions

Cisplatin 117 Oxaliplatin 111 Fluorouracil 100 Capecitabine 90 Docetaxel 69 Leucovorin 60 Irinotecan 57 Paclitaxel 49 S 1 (combination) 38 pembrolizumab 35 Trastuzumab 31 Radiotherapy 25 Bevacizumab 20 Nivolumab 19 Epirubicin 19 titanium silicide 18 Surgical Procedures, Operative 17 Carboplatin 17 Ramucirumab 16 Cetuximab 15 Gastrectomy 13 apatinib 12 Everolimus 12 Gemcitabine 11 Albumin-Bound Paclitaxel 10 Neoadjuvant Therapy 8 Folfox protocol 8 Drug Therapy 8 Chemotherapy, Adjuvant 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × Acetylcysteine × Clear all

NCT01653171 2018-04-10

PRUE

Pontificia Universidad Catolica de Chile

Phase 4 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡